Djembatan Dua is primarily engaged in pharmaceuticals activity. Its headquarters is located in Banten. The company was founded in 1962. Djembatan Dua was established by a group of visionary entrepreneurs with a mission to provide high-quality pharmaceutical products to the Indonesian market. Over the years, the company has expanded its operations to include both primary and secondary business lines, focusing on the manufacturing and distribution of generic and branded pharmaceuticals. The company operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Medan. Djembatan Dua's product portfolio includes a wide range of medicines, including antibiotics, analgesics, and cardiovascular drugs, marketed under well-known brand names. In addition to its domestic operations, Djembatan Dua has extended its reach to international markets, exporting its products to several countries in Southeast Asia. The company has established partnerships with various international pharmaceutical firms to enhance its research and development capabilities. Djembatan Dua is a member of several industry associations, including the Indonesian Pharmaceutical Association, which helps it stay at the forefront of industry trends and regulatory changes. The company is committed to maintaining high standards of quality and safety in its manufacturing processes. With a vision to improve healthcare outcomes, Djembatan Dua aims to innovate and expand its product offerings continually. The company is dedicated to making healthcare accessible and affordable, aligning its mission with the broader goal of enhancing the quality of life for communities it serves.
Headquarters
Blok B7/B1, Bintaro Jaya Sektor 7
Tigaraksa; Banten;
Postal Code: 15224
Contact Details: Purchase the PT Djembatan Dua report to view the information.
Website: http://www.djembatandua.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service